ACR Open Rheumatology, 2026
Macrophage Activation Syndrome–Associated Proteins and Enhanced Interferon‐γ Responsiveness in the Plasma Proteome of Patients With Multisystem Inflammatory Syndrome in Children in a Pretreatment Replication Single‐Center Cohort

McCuaig S., Toland C., Konvinse K. et al.

PLOS Genetics, 2026
Shared latent genetic liability across fibromyalgia and psychiatric traits: Novel insights from genomic structural equation modeling

Lin L., Li Y., Ji F. et al.

Cytotherapy, 2026
Comparative Profiling of ASC Products Following Harvest with DisoNNex and TrypLE

Johansen E., Bangsgaard S., Lethager L. et al.

Nature Communications, 2026
Cross-ancestry comparison of aptamer and antibody protein measures

Nicholas J., Katz D., Tahir U. et al.

GigaScience, 2026
High-definition likelihood inference of genetic colocalization reveals protein biomarkers for human complex diseases

Li Y., Zhai R., Yang Z. et al.

Diabetologia, 2026
Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes

Syreeni A., Dahlström E., Smyth L. et al.

Investigative Ophthalmology & Visual Science, 2026
Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype

Lv K., Peng J., Wang H. et al.

Kidney International, 2026
Sodium glucose transporter 2 inhibition maintains kidney antibacterial response by decreasing complement C1q

Sendtner G., Miranda J., Naumann P. et al.

Molecular Therapy, 2026
Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors

Clubb J., Pakola S., Joenväärä S. et al.

Signal Transduction and Targeted Therapy, 2026
Multiomics Mendelian randomization identifies serpin family G member 1 as a chronic obstructive pulmonary disease modulator

Yi E., Cui J., Wang H. et al.

Cardiovascular Diabetology, 2026
Chronic kidney disease onset, progression, and cardiovascular outcomes: proteomics informs biology and risk stratification

Zhang J., Yu H., Song X. et al.

European Stroke Journal, 2026
Elevated acute-phase plasma levels of S100A12 [EN-RAGE] are associated with vascular recurrence after ischemic stroke

Granelli B., Angerfors A., Furutjäll S. et al.

Annals of Hematology, 2026
Mendelian randomization analysis of immune cell subsets and inflammatory cytokines in aplastic anaemia

Hu K., Cheng Y., Xiao G. et al.

Journal of Human Genetics, 2026
Meta-analyses of genome-wide association studies identify novel loci influencing Japanese white matter hyperintensities

Asanomi Y., Mitsumori R., Yamakawa A. et al.

Molecular Therapy Advances, 2026
The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humans

Ryberg E., Bergström F., Sten S. et al.

Medicine, 2026
Association of programmed cell death with atrial fibrillation risk: A multi-omics Mendelian randomization study

Liu K., Han X., Chen Y.

Microorganisms, 2026
Immune Dysregulation and Cytokine Profiling in Acute Mycoplasma pneumoniae Pneumonia

Wen Y., Zhai Y., Sang S. et al.

Biomedicine & Pharmacotherapy, 2026
Integrated transcriptomic and proteomic profiling identifies an interferon-dependent inflammatory endotype in sepsis

Fratea A., Riza A., Dumitrescu F. et al.

Clinical Pharmacology in Drug Development, 2026
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies

Vendel A., Benichou O., Chang C. et al.

Journal of Ethnopharmacology, 2026
OLink proteomic biomarker to predict clinical efficacy of Macaranga sinensis Müll.Arg: A nested case-control study

Chen G., Zhou S., Chen Y. et al.